Influenza virus haemagglutinin
Current shortage
The TGA records this medicine as being in shortage now. A shortage often affects some brands, strengths or pack sizes and not others, so a supply of the medicine may still be available. Your pharmacist can tell you what is in stock and what alternatives exist.
The TGA has assessed this shortage as low impact, meaning alternatives are generally available and most people can be managed without difficulty.
3 product records on the Australian Register of Therapeutic Goods, listed in full below. The TGA last updated this information on 2 June 2026. Not medical advice.
The TGA does not publish a reason for a shortage, so Voxsanity cannot show one. Nothing on this page is an explanation of why supply is affected — that information is not in the source and is not inferred here.
This is national information. The TGA records shortages for Australia as a whole. There is no state, territory or pharmacy-level stock information in this data, and Voxsanity cannot tell you whether a particular pharmacy has a medicine in stock. Your pharmacist can.
Products affected
FLUAD inactivated influenza vaccine (surface antigen) suspension for injection, adjuvanted, needle-free 0.5 mL syringe
Injection, suspension · ARTG 306718
- Status
- Current shortage The TGA records this medicine as being in shortage now. A shortage often affects some brands, strengths or pack sizes and not others, so a supply of the medicine may still be available. Your pharmacist can tell you what is in stock and what alternatives exist.
- Supply
- Limited Availability The supplier reports limited stock.
- TGA impact rating
- Low impact The TGA has assessed this shortage as low impact, meaning alternatives are generally available and most people can be managed without difficulty.
- Reported from
- 6 July 2026 The TGA's dates span 8 months.
- Expected to be resolved
- 1 March 2027 This is the date the supplier has given the TGA. It can move.
- TGA last updated
- 2 June 2026
What the TGA says is being done
Supply will remain available under the National Immunisation Program until depleted for this influenza season.
Quoted from the TGA's own record for this product. Voxsanity has not edited, summarised or interpreted it.
INFLUVAC influenza virus haemagglutinin 0.5 mL vaccine prefilled syringe with 16 mm needle
Injection, suspension · ARTG 432790
- Status
- Current shortage The TGA records this medicine as being in shortage now. A shortage often affects some brands, strengths or pack sizes and not others, so a supply of the medicine may still be available. Your pharmacist can tell you what is in stock and what alternatives exist.
- Supply
- Unavailable The supplier reports no stock is available.
- TGA impact rating
- Low impact The TGA has assessed this shortage as low impact, meaning alternatives are generally available and most people can be managed without difficulty.
- Reported from
- 29 April 2026 The TGA's dates span 10 months.
- Expected to be resolved
- 26 February 2027 This is the date the supplier has given the TGA. It can move.
- TGA last updated
- 6 May 2026
What the TGA says is being done
The sponsor has advised from 29 April 2026 all stock of this vaccine will have been distributed to wholesalers. Stock will be available for supply under the National Immunisation Program or private market until depleted for this influenza season.
Quoted from the TGA's own record for this product. Voxsanity has not edited, summarised or interpreted it.
INFLUVAC TETRA influenza virus haemagglutinin 0.5mL vaccine prefilled syringe with 16 mm needle
Suspension · ARTG 292237
- Status
- Discontinued The supplier has told the TGA it is permanently stopping supply of this product in Australia. This is not a temporary shortage. Other brands or strengths of the same medicine may still be available, and your doctor or pharmacist can advise on what to do next.
- Supply
- Unavailable The supplier reports no stock is available.
- TGA impact rating
- Low impact The TGA has assessed this shortage as low impact, meaning alternatives are generally available and most people can be managed without difficulty.
- Reported from
- 24 April 2026
- Expected to be resolved
- The TGA does not publish an end date for this record (it records "Unknown"). Voxsanity does not estimate one.
- TGA last updated
- 28 April 2026
What the TGA says is being done
This product is being replaced by INFLUVAC influenza virus haemagglutinin 0.5 mL vaccine prefilled syringe with 16 mm needle - (ARTG 432790)
Quoted from the TGA's own record for this product. Voxsanity has not edited, summarised or interpreted it.
Where this comes from
Source: Medicine Shortage Reports Database, Therapeutic Goods Administration (TGA), © Commonwealth of Australia, reproduced with permission. The TGA does not endorse Voxsanity, and nothing here is presented as a TGA view. Shortage information is free for everyone on this site, with no account and no subscription.
To read the TGA's own entry for Influenza virus haemagglutinin, open the TGA Medicine Shortage Reports Database and type Influenza virus haemagglutinin into its filter box. The TGA's register has no direct link to an individual medicine, so this is the closest link that exists. General information about medicine shortages is on the TGA's medicine shortages page.
Voxsanity last read the register on 18 August 2026.
Not medical advice. Voxsanity republishes public government health data in plain English. Speak to your pharmacist or doctor about your own medicines. Do not stop or change how you take a medicine because of anything on this page.